hit counter
Ampio Pharmaceuticals, Inc. (AMPE) Stock News Sentiment & Price - Sentifly
AMPE - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Ampio Pharmaceuticals, Inc. (AMPE)

USA
Biotechnology
NYSE
AMPE Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
AMPE Latest news
Seeking Alpha
Neutral
Ampio Pharmaceuticals, Inc. (AMPE) Q3 2021 Results - Earnings Call Transcript
2021-11-10 22:17

Ampio Pharmaceuticals, Inc. (AMPE) Q3 2021 Results - Earnings Call Transcript

PRNewsWire
Neutral
Ampio Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides Business Update
2021-11-10 16:01

ENGLEWOOD, Colo., Nov. 10, 2021 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for common inflammatory conditions, today reported results for the three- and nine-month periods ended September 30, 2021 and provided a corporate overview and business update.

PRNewsWire
Neutral
Ampio Pharmaceuticals Strengthens Management Team and Board of Directors
2021-10-13 09:15

ENGLEWOOD, Colo., Oct. 13, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammatory conditions, today announced the appointments of Howard Levy, M.B.B.Ch.

PRNewsWire
Neutral
Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India
2021-09-21 09:15

ENGLEWOOD, Colo., Sept. 21, 2021 /PRNewswire/ --  Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced regulatory approval from the Drugs Controller General of India (DCGI) of the Central Drugs Standard Control Organization (CDSCO) in the Phase II AP-019 clinical trial in India.

PennyStocks
Positive
Best Penny Stocks For Retail Traders to Buy? 3 For Your List
2021-09-16 15:07

Investing in penny stocks right now? Check these three small caps out for your watchlist The post Best Penny Stocks For Retail Traders to Buy?

PennyStocks
Positive
Penny Stocks For Your Biotech Watch List In September 2021
2021-09-15 11:04

Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PRNewsWire
Neutral
Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK)
2021-09-15 09:15

ENGLEWOOD, Colo., Sept. 15, 2021 /PRNewswire/ --  Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced top-line results from AP-013, a randomized, saline-controlled, double-blind Phase III clinical study evaluating the efficacy of an intra-articular (IA) injection of Ampion™ in adults with pain due to severe osteoarthritis of the knee (OAK).

PRNewsWire
Neutral
Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action
2021-08-13 09:15

ENGLEWOOD, Colo., Aug. 13, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, today announced a preprint version of a manuscript, "LMWF5A Demonstrates an Anti-Inflammatory Mode of Action and Similar Drug Targets to Dexamethasone in Activated PBMC," has been posted on In Review, a preprint platform hosted on Research Square.

PRNewsWire
Neutral
Ampio Pharmaceuticals Reminds Stockholders to Vote Shares in Advance of 2021 Annual Meeting
2021-08-12 09:15

ENGLEWOOD, Colo., Aug. 12, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, reminds stockholders to vote on the proposals listed in the Company's proxy statement in advance of its upcoming annual meeting.

PRNewsWire
Neutral
Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
2021-08-11 09:15

ENGLEWOOD, Colo., Aug. 11, 2021 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, today announced that the company will host one-on-one investor meetings at the following investor conferences: H.C.

Loading more news...